Amneal Pharmaceuticals, Inc. (AMRX) Net Income by Year
Amneal Pharmaceuticals, Inc. reported $72.1M in net income in fiscal year 2025. This represents an increase of 161.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $157.4M in net income. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Amneal Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AMRX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
AMRX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Amneal Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Amneal Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Amneal Pharmaceuticals, Inc. reported $72.1M in net income in fiscal year 2025.
How fast is Amneal Pharmaceuticals, Inc.'s net income growing?
Amneal Pharmaceuticals, Inc. (AMRX) net income rose by 161.6% year over year, from -$116.9M to $72.1M in fiscal year 2025.
What is Amneal Pharmaceuticals, Inc.'s net income over the last twelve months?
Amneal Pharmaceuticals, Inc. (AMRX) reported $157.4M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Amneal Pharmaceuticals, Inc.'s net income changed over the years?
Across the 10 fiscal years this page covers, Amneal Pharmaceuticals, Inc. (AMRX) net income went from $0 in fiscal year 2016 to $72.1M in fiscal year 2025.
What was Amneal Pharmaceuticals, Inc.'s net income in the most recent quarter?
Amneal Pharmaceuticals, Inc. (AMRX) reported $57.7M in net income in Q2 2026. This represents an increase of 157.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Amneal Pharmaceuticals, Inc. (AMRX) reported on that line in every period on record.